308 related articles for article (PubMed ID: 16387742)
1. Naturally occurring coumarins inhibit 7,12-dimethylbenz[a]anthracene DNA adduct formation in mouse mammary gland.
Prince M; Campbell CT; Robertson TA; Wells AJ; Kleiner HE
Carcinogenesis; 2006 Jun; 27(6):1204-13. PubMed ID: 16387742
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring coumarins inhibit human cytochromes P450 and block benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene DNA adduct formation in MCF-7 cells.
Kleiner HE; Reed MJ; DiGiovanni J
Chem Res Toxicol; 2003 Mar; 16(3):415-22. PubMed ID: 12641443
[TBL] [Abstract][Full Text] [Related]
3. Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents.
Izzotti A; Camoirano A; Cartiglia C; Grubbs CJ; Lubet RA; Kelloff GJ; De Flora S
Cancer Res; 1999 Sep; 59(17):4285-90. PubMed ID: 10485473
[TBL] [Abstract][Full Text] [Related]
4. Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation.
Kleiner HE; Vulimiri SV; Reed MJ; Uberecken A; DiGiovanni J
Chem Res Toxicol; 2002 Feb; 15(2):226-35. PubMed ID: 11849049
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of naturally occurring coumarins leads to altered phase I and II enzyme activities and reduced DNA adduct formation by polycyclic aromatic hydrocarbons in various tissues of SENCAR mice.
Kleiner HE; Vulimiri SV; Miller L; Johnson WH; Whitman CP; DiGiovanni J
Carcinogenesis; 2001 Jan; 22(1):73-82. PubMed ID: 11159744
[TBL] [Abstract][Full Text] [Related]
6. Purple grape juice inhibits 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation.
Jung KJ; Wallig MA; Singletary KW
Cancer Lett; 2006 Feb; 233(2):279-88. PubMed ID: 15878797
[TBL] [Abstract][Full Text] [Related]
7. Effect of naturally occurring coumarins on the formation of epidermal DNA adducts and skin tumors induced by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in SENCAR mice.
Cai Y; Kleiner H; Johnston D; Dubowski A; Bostic S; Ivie W; DiGiovanni J
Carcinogenesis; 1997 Aug; 18(8):1521-7. PubMed ID: 9276625
[TBL] [Abstract][Full Text] [Related]
8. Suppression of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis by pre-initiation treatment of rats with beta-naphthoflavone coincides with decreased levels of the carcinogen-derived DNA adducts in the mammary gland.
Malejka-Giganti D; Bennett KK; Culp SJ; Beland FA; Shinozuka H; Bliss RL
Cancer Detect Prev; 2005; 29(4):338-47. PubMed ID: 16054776
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate.
el-Bayoumy K; Chae YH; Upadhyaya P; Meschter C; Cohen LA; Reddy BS
Cancer Res; 1992 May; 52(9):2402-7. PubMed ID: 1568209
[TBL] [Abstract][Full Text] [Related]
10. Correlation between formation of a specific hydrocarbon-deoxyribonucleoside adduct and tumor-initiating activity of 7,12-dimethylbenz(a)anthracene and its 9- and 10-monofluoroderivatives in mice.
DiGiovanni J; Sawyer TW; Fisher EP
Cancer Res; 1986 Sep; 46(9):4336-41. PubMed ID: 3089589
[TBL] [Abstract][Full Text] [Related]
11. DNA adduct formation by 7,12-dimethylbenz[a]anthracene and its noncarcinogenic 2-fluoro analogue in female Sprague-Dawley rats.
Daniel FB; Joyce NJ
J Natl Cancer Inst; 1983 Jan; 70(1):111-8. PubMed ID: 6401826
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of the citrus coumarin, isopimpinellin, blocks DNA adduct formation and skin tumor initiation by 7,12-dimethylbenz[a]anthracene in SENCAR mice.
Kleiner HE; Vulimiri SV; Starost MF; Reed MJ; DiGiovanni J
Carcinogenesis; 2002 Oct; 23(10):1667-75. PubMed ID: 12376476
[TBL] [Abstract][Full Text] [Related]
13. Determination of benzo[a]pyrene- and 7,12-dimethylbenz[a]anthracene-DNA adducts formed in rat mammary glands.
Todorovic R; Ariese F; Devanesan P; Jankowiak R; Small GJ; Rogan E; Cavalieri E
Chem Res Toxicol; 1997 Sep; 10(9):941-7. PubMed ID: 9305574
[TBL] [Abstract][Full Text] [Related]
14. Tissue distribution of DNA adducts in rats treated by intramammillary injection with dibenzo[a,l]pyrene, 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene.
Arif JM; Smith WA; Gupta RC
Mutat Res; 1997 Aug; 378(1-2):31-9. PubMed ID: 9288883
[TBL] [Abstract][Full Text] [Related]
15. Formation of benzylic-DNA adducts resulting from 7,12-dimethylbenz[a]anthracene in vivo.
Ravi Kumar MN; Vadhanam MV; Horn J; Flesher JW; Gupta RC
Chem Res Toxicol; 2005 Apr; 18(4):686-91. PubMed ID: 15833028
[TBL] [Abstract][Full Text] [Related]
16. Ellagic acid effects on the carcinogenicity, DNA-binding and metabolism of 7,12-dimethylbenz(a)anthracene (DMBA).
Singletary K; Liao CH
In Vivo; 1989; 3(3):173-5. PubMed ID: 2519851
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of naturally occurring coumarins on the metabolic activation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured mouse keratinocytes.
Cai Y; Baer-Dubowska W; Ashwood-Smith M; DiGiovanni J
Carcinogenesis; 1997 Jan; 18(1):215-22. PubMed ID: 9054609
[TBL] [Abstract][Full Text] [Related]
18. Covalent binding of 7,12-dimethylbenz(a)anthracene and 10-fluoro-7,12-dimethylbenz(a)anthracene to mouse epidermal DNA and its relationship to tumor-initiating activity.
DiGiovanni J; Fisher EP; Aalfs KK; Prichett WP
Cancer Res; 1985 Feb; 45(2):591-7. PubMed ID: 3917851
[TBL] [Abstract][Full Text] [Related]
19. Effects of selenium on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis and DNA adduct formation.
Ip C; Daniel FB
Cancer Res; 1985 Jan; 45(1):61-5. PubMed ID: 3917375
[TBL] [Abstract][Full Text] [Related]
20. The aspirin metabolite, salicylate, inhibits 7,12-dimethylbenz[a]anthracene-DNA adduct formation in breast cancer cells.
Abbadessa G; Spaccamiglio A; Sartori ML; Nebbia C; Dacasto M; Di Carlo F; Racca S
Int J Oncol; 2006 May; 28(5):1131-40. PubMed ID: 16596229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
